What is Vericel's R&D?

Vericel (VCEL) reported R&D of $8.1M in Q1 2026.

How has Vericel's R&D changed year-over-year?

Vericel's R&D increased by 11.6% year-over-year, from $7.26M to $8.1M.

What is the long-term trend for Vericel's R&D?

Over 4 years (2021 to 2025), Vericel's R&D has grown at a 14.1% compound annual growth rate (CAGR), from $16.29M to $27.56M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Vericel VCEL R&D

R&D at other companies

StrykerSYK

$413M+2.0%

Zimmer Biomet HoldingsZBH

$103.4M-6.5%

LeMaitre VascularLMAT

$4.06M-0.9%

Capricor TherapeuticsCAPR

$27.38M+44.7%

Other financials

Income statement

See full

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

See full

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

See full

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

See full

Market cap$2.13B-26.8%

Profitability

See full

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

See full

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vericel's R&D?: Vericel (VCEL) reported R&D of $8.1M in Q1 2026.
How has Vericel's R&D changed year-over-year?: Vericel's R&D increased by 11.6% year-over-year, from $7.26M to $8.1M.
What is the long-term trend for Vericel's R&D?: Over 4 years (2021 to 2025), Vericel's R&D has grown at a 14.1% compound annual growth rate (CAGR), from $16.29M to $27.56M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.